Bernat Queralt

Name:
Bernat Queralt
Sign: Bernat Queralt
Position:
Metges Investigadors
Read More

Main researcher

Joan Figueras Felip 

 

Post-doctorate researchers

Mª José Ferri Iglesias

Rosa Peracaula

 

Spanish

Are you investigator?

English

If you research if you are interested in helping with any of our research groups, fill out this form. We will contact you as soon as possible. Thank you.

Send us your details

Read More
Read More

 

Main researcher

Joan Figueras Felip 

 

Post-doctorate researchers

MªJosé Ferri Iglesias

Rosa Peracaula

 

Pre-doctorate researchers

Julia Gil Garcia

Helena Salvador Roses

English

Are you investigator?

English

If you research if you are interested in helping with any of our research groups, fill out this form. We will contact you as soon as possible. Thank you.

Send us your details

Read More

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.

Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.

BACKGROUND: We previously reported a 35% overall response rate (ORR) with biweekly 5-fluorouracil (5-FU) continuous infusion (TTD [Spanish Cooperative Group for Digestive Tumour Therapy] schedule) plus irinotecan as first-line therapy in elderly patients with metastatic colorectal cancer (mCRC). The present study also was carried out in elderly patients to determine the efficacy and safety of the same 5-FU schedule plus oxaliplatin.

Undefined
Read More
Subscribe to Bernat Queralt